| 摘要 |
The present invention relates to peptides that inhibit telomerase, and uses of these peptides, particularly in a method of treating cancer. The invention includes telomerase inhibitory peptides having an amino sequence of GARTFRRXKRAXRLTSRVK (SEQ ID NO:1) (wherein X is E or Q) or functional equivalents or fragments thereof. The invention also includes a nucleotide sequence which encodes the telomerase inhibitory peptide (TEIPP).
|
